New York, NY -- (SBWIRE) -- 01/24/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: SK3 Group Inc(OTCMKTS:SKTO) , mCig Inc(OTCBB:MCIG) ,Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) ,Elite Pharmaceuticals Inc(OTCBB:ELTP)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
SK3 Group Inc(OTCMKTS:SKTO) managed to keep its gain at 0.53% on below-normal volume of 8.73M shares. The stock is at $0.0191, floating in a range of $0.02 - 0.02. Its latest price has reached market capitalization of $11.33M. Its 52-week range has been $0.00 - 0.08. SK3 Group, Inc. (SK3), formerly CTT International Distributors Inc., is a development-stage company. The Company was formed by the merger of Slabsdirect.com, Inc.
What SKTO Charts Are Signaling for Traders? Find Out Here
mCig Inc(OTCBB:MCIG) is trading on a volume of 6.15M Shares, higher than its standard daily volume. Shares are at $0.272. Over the last twelve months, the stock has lost -23.36% and faced a worst price of $0.00. mCig, Inc., formerly LifeTech Industries Inc., is a development-stage company. The Company is developing a day spa business in the areas of Montrose.
Should MCIG a Buy or Sell Now? Find Out Here
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) settled up at $2.94 on above-normal volume of 7.32M shares during the recent trading session. The stock has its 12-month range $ 0.56 - 6.03. It is trading in a range of $ 2.15 - 2.98 today. Provectus Biopharmaceuticals Inc, formerly Provectus Pharmaceuticals, Inc., is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
Can PVCT Show a Strong Recovery? Find out in This Research Report
In the recent trading session, Elite Pharmaceuticals Inc(OTCBB:ELTP) is on high volume, trading at a volume of versus its average daily volume ratio 5.31M/5.17M shares. At $0.300, the stock has attained market capitalization of 152.08M. Elite Pharmaceuticals, Inc. (Elite) is a specialty pharmaceutical company principally engaged in the development and manufactures of oral.
Where ELTP is Headed Exactly? Find out in This Trend Analysis Reports
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)